Literature DB >> 24172824

Feasibility of targeted next-generation sequencing of the TP53 and ATM genes in chronic lymphocytic leukemia.

L Mansouri1, L-A Sutton1, V Ljungström1, E F Sörqvist1, R Gunnarsson2, K E Smedby3, G Juliusson4, K Stamatopoulos5, M Nilsson6, R Rosenquist1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24172824     DOI： 10.1038/leu.2013.322

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  16 in total

1.  TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutations.

Authors:  T Zenz; D Vollmer; M Trbusek; J Smardova; A Benner; T Soussi; H Helfrich; M Heuberger; P Hoth; M Fuge; T Denzel; S Häbe; J Malcikova; P Kuglik; S Truong; N Patten; L Wu; D Oscier; R Ibbotson; A Gardiner; I Tracy; K Lin; A Pettitt; S Pospisilova; J Mayer; M Hallek; H Döhner; S Stilgenbauer
Journal:  Leukemia       Date:  2010-09-23       Impact factor: 11.528

2.  Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: a high-resolution genomic screening of newly diagnosed patients.

Authors:  R Gunnarsson; A Isaksson; M Mansouri; H Göransson; M Jansson; N Cahill; M Rasmussen; J Staaf; J Lundin; S Norin; A M Buhl; K E Smedby; H Hjalgrim; K Karlsson; J Jurlander; G Juliusson; R Rosenquist
Journal:  Leukemia       Date:  2009-09-10       Impact factor: 11.528

Review 3.  TP53 aberrations in chronic lymphocytic leukemia.

Authors:  Martin Trbusek; Jitka Malcikova
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

Review 4.  ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia.

Authors:  S Pospisilova; D Gonzalez; J Malcikova; M Trbusek; D Rossi; A P Kater; F Cymbalista; B Eichhorst; M Hallek; H Döhner; P Hillmen; M van Oers; J Gribben; P Ghia; E Montserrat; S Stilgenbauer; T Zenz
Journal:  Leukemia       Date:  2012-02-02       Impact factor: 11.528

5.  Evolution and impact of subclonal mutations in chronic lymphocytic leukemia.

Authors:  Dan A Landau; Scott L Carter; Petar Stojanov; Aaron McKenna; Kristen Stevenson; Michael S Lawrence; Carrie Sougnez; Chip Stewart; Andrey Sivachenko; Lili Wang; Youzhong Wan; Wandi Zhang; Sachet A Shukla; Alexander Vartanov; Stacey M Fernandes; Gordon Saksena; Kristian Cibulskis; Bethany Tesar; Stacey Gabriel; Nir Hacohen; Matthew Meyerson; Eric S Lander; Donna Neuberg; Jennifer R Brown; Gad Getz; Catherine J Wu
Journal:  Cell       Date:  2013-02-14       Impact factor: 41.582

6.  ATM mutations uniformly lead to ATM dysfunction in chronic lymphocytic leukemia: application of functional test using doxorubicin.

Authors:  Veronika Navrkalova; Ludmila Sebejova; Jana Zemanova; Jana Kminkova; Blanka Kubesova; Jitka Malcikova; Marek Mraz; Jana Smardova; Sarka Pavlova; Michael Doubek; Yvona Brychtova; David Potesil; Veronika Nemethova; Jiri Mayer; Sarka Pospisilova; Martin Trbusek
Journal:  Haematologica       Date:  2013-04-12       Impact factor: 9.941

Review 7.  From pathogenesis to treatment of chronic lymphocytic leukaemia.

Authors:  Thorsten Zenz; Daniel Mertens; Ralf Küppers; Hartmut Döhner; Stephan Stilgenbauer
Journal:  Nat Rev Cancer       Date:  2009-12-03       Impact factor: 60.716

8.  Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.

Authors:  Michael Hallek; Bruce D Cheson; Daniel Catovsky; Federico Caligaris-Cappio; Guillaume Dighiero; Hartmut Döhner; Peter Hillmen; Michael J Keating; Emili Montserrat; Kanti R Rai; Thomas J Kipps
Journal:  Blood       Date:  2008-01-23       Impact factor: 22.113

Review 9.  The genomic landscape of chronic lymphocytic leukemia: clinical implications.

Authors:  Víctor Quesada; Andrew J Ramsay; David Rodríguez; Xose S Puente; Elías Campo; Carlos López-Otín
Journal:  BMC Med       Date:  2013-05-09       Impact factor: 8.775

10.  Targeted resequencing of candidate genes using selector probes.

Authors:  H Johansson; M Isaksson; E Falk Sörqvist; F Roos; J Stenberg; T Sjöblom; J Botling; P Micke; K Edlund; S Fredriksson; H Göransson Kultima; Olle Ericsson; Mats Nilsson
Journal:  Nucleic Acids Res       Date:  2010-11-08       Impact factor: 16.971
View more
  6 in total

1.  microRNA-34b/c on chromosome 11q23 is aberrantly methylated in chronic lymphocytic leukemia.

Authors:  Stefan Deneberg; Meena Kanduri; Dina Ali; Sofia Bengtzen; Mohsen Karimi; Ying Qu; Eva Kimby; Larry Mansouri; Richard Rosenquist; Andreas Lennartsson; Sören Lehmann
Journal:  Epigenetics       Date:  2014-03-31       Impact factor: 4.528

2.  Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting.

Authors:  Lesley-Ann Sutton; Viktor Ljungström; Larry Mansouri; Emma Young; Diego Cortese; Veronika Navrkalova; Jitka Malcikova; Alice F Muggen; Martin Trbusek; Panagiotis Panagiotidis; Frederic Davi; Chrysoula Belessi; Anton W Langerak; Paolo Ghia; Sarka Pospisilova; Kostas Stamatopoulos; Richard Rosenquist
Journal:  Haematologica       Date:  2014-12-05       Impact factor: 9.941

Review 3.  Deciphering the molecular landscape in chronic lymphocytic leukemia: time frame of disease evolution.

Authors:  Lesley-Ann Sutton; Richard Rosenquist
Journal:  Haematologica       Date:  2015-01       Impact factor: 9.941

4.  Spectrum of gene mutations identified by targeted next-generation sequencing in Chinese leukemia patients.

Authors:  Hongxia Yao; Congming Wu; Yueqing Chen; Li Guo; Wenting Chen; Yanping Pan; Xiangjun Fu; Guyun Wang; Yipeng Ding
Journal:  Mol Genet Genomic Med       Date:  2020-07-07       Impact factor: 2.183

5.  Comparative analysis of targeted next-generation sequencing panels for the detection of gene mutations in chronic lymphocytic leukemia: an ERIC multi-center study.

Authors:  Lesley-Ann Sutton; Viktor Ljungström; Anna Enjuanes; Diego Cortese; Aron Skaftason; Eugen Tausch; Katerina Stano Kozubik; Ferran Nadeu; Marine Armand; Jikta Malcikova; Tatjana Pandzic; Jade Forster; Zadie Davis; David Oscier; Davide Rossi; Paolo Ghia; Jonathan C Strefford; Sarka Pospisilova; Stephan Stilgenbauer; Frederic Davi; Elias Campo; Kostas Stamatopoulos; Richard Rosenquist
Journal:  Haematologica       Date:  2021-03-01       Impact factor: 9.941

6.  Five Percent Variant Allele Frequency Is a Reliable Reporting Threshold for TP53 Variants Detected by Next Generation Sequencing in Chronic Lymphocytic Leukemia in the Clinical Setting.

Authors:  Tatjana Pandzic; Claes Ladenvall; Marie Engvall; Mattias Mattsson; Monica Hermanson; Lucia Cavelier; Viktor Ljungström; Panagiotis Baliakas
Journal:  Hemasphere       Date:  2022-08-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.